CSF2 and congenital rubella syndrome: In a mouse model of CRS, research studies demonstrated that the early administration of Dasatinib after CAR-T infusion can reduce the levels of Ifn-γ, Tnf-α, Gm-csf, and Il-2 in mice and significantly reduce the mortality of mice.